- Recommendation ID
- DG36/2
- Question
secondary research is recommended to understand the clinical validity of enzyme-linked immunosorbent assay (ELISA) tests, that is the correlation between ELISA test results and health outcomes or states, such as remission, response, low or high disease activity or flares in rheumatoid arthritis
- Any explanatory notes
(if applicable)
Source guidance details
- Comes from guidance
- Therapeutic monitoring of TNF-alpha inhibitors in rheumatoid arthritis
- Number
- DG36
- Date issued
- July 2019
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 31/07/2019 |